Market revenue in 2023 | USD 9,304.3 million |
Market revenue in 2030 | USD 13,051.7 million |
Growth rate | 5% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Fresh Donor |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.34% in 2023. Horizon Databook has segmented the Europe in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
In 2022, Europe emerged as the dominant region in the IVF market, accounting for the largest revenue share. Growth of the IVF market in Europe is being driven by an increase in medical tourism. A rising number of individuals from the U.S. are opting to travel to the Czech Republic to access more affordable IVF treatments.
In addition, individuals who cannot afford to travel to Europe are seeking IVF treatments domestically at approximately one-third of the cost charged by clinics in the U.S. The cost of IVF treatments in the U.S. is estimated to be around USD 25,000, encompassing processes such as fertilization and growth & development of the egg.
Utilizing an egg donor in the IVF process may result in a higher cost, typically around USD 30,000. The affordability and accessibility of IVF treatments abroad have contributed to growth of medical tourism, attracting individuals seeking more affordable options to fulfill their reproductive aspirations.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe in vitro fertilization market , including forecasts for subscribers. This continent databook contains high-level insights into Europe in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account